The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma
Hepatology2013Vol. 57(6), pp. 2261–2273
Citations Over TimeTop 1% of 2013 papers
Wolfgang Sieghart, Florian Hucke, Matthias Pinter, Ivo Graziadei, Wolfgang Vogel, Christian Müller, Harald Heinzl, Michael Trauner, Markus Peck‐Radosavljevic
Abstract
An ART score of ≥2.5 prior the second TACE identifies patients with a dismal prognosis who may not profit from further TACE sessions. (HEPATOLOGY 2013;57:2261-2273).
Related Papers
- Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.(2003)
- Spontaneous rupture of hepatocellular carcinoma.(2002)
- Pathology of hepatocellular carcinoma(2006)
- The medical management of hepatocellular carcinoma (HCC) in Japan: a review with implications for HCC seen in the west.(1997)
- Analysis of the influence factors of serum alpha-fetoprotein levels in patients with hepatocellular carcinoma(2001)